A Novel, Heterozygous Three Base-Pair Deletion in CARD11 Results in B Cell Expansion with NF-κB and T Cell Anergy Disease.
B-Lymphocytes
/ physiology
Base Pairing
/ genetics
CARD Signaling Adaptor Proteins
/ genetics
Cell Proliferation
Cells, Cultured
Child
Child, Preschool
Clonal Anergy
Female
Guanylate Cyclase
/ genetics
Heterozygote
Humans
Immunologic Deficiency Syndromes
/ genetics
Infant
Lymphocyte Activation
Lymphocytosis
/ genetics
NF-kappa B
/ metabolism
Sequence Deletion
/ genetics
T-Lymphocytes
/ immunology
BENTA
CARD11
Primary immunodeficiency
Journal
Journal of clinical immunology
ISSN: 1573-2592
Titre abrégé: J Clin Immunol
Pays: Netherlands
ID NLM: 8102137
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
received:
26
02
2019
accepted:
26
11
2019
pubmed:
4
1
2020
medline:
3
7
2021
entrez:
4
1
2020
Statut:
ppublish
Résumé
Germline gain-of-function mutations in CARD11 lead to the primary immunodeficiency, B cell expansion with NF-κB, and T cell anergy (BENTA). Herein, we report the case of a girl, presenting at 2 years of age with lymphocytosis and splenomegaly in whom a novel, in-frame, three base pair deletion in CARD11 was identified resulting in the deletion of a single lysine residue (K215del) from the coiled-coil domain. In vitro functional assays demonstrated that this variant leads to a subtle increase in baseline NF-κB signaling and impaired proliferative responses following T cell receptor and mitogenic stimulation. Previously reported immunological defects associated with BENTA appear mild in our patient who is now 6 years of age; a B cell lymphocytosis and susceptibility to upper respiratory tract infections persist; however, she has broad, sustained responses to protein-polysaccharide conjugate vaccines and displays normal proliferative responses to ex vivo T cell stimulation.
Identifiants
pubmed: 31897776
doi: 10.1007/s10875-019-00729-x
pii: 10.1007/s10875-019-00729-x
doi:
Substances chimiques
CARD Signaling Adaptor Proteins
0
NF-kappa B
0
CARD11 protein, human
EC 4.6.1.2
Guanylate Cyclase
EC 4.6.1.2
Types de publication
Case Reports
Letter
Langues
eng
Sous-ensembles de citation
IM
Pagination
406-411Références
Immunity. 2003 Jun;18(6):763-75
pubmed: 12818158
J Exp Med. 2012 Nov 19;209(12):2247-61
pubmed: 23129749
Front Immunol. 2017 Aug 02;8:913
pubmed: 28824638
J Allergy Clin Immunol. 2015 Sep;136(3):819-821.e1
pubmed: 25930198
Br J Cancer. 2004 Jul 19;91(2):355-8
pubmed: 15188009
Front Immunol. 2018 Jun 14;9:1049
pubmed: 29963038
J Exp Med. 2012 Oct 22;209(11):1907-17
pubmed: 23027925
PLoS One. 2012;7(10):e46688
pubmed: 23056405
Front Immunol. 2018 Feb 08;9:198
pubmed: 29472930
Cytometry B Clin Cytom. 2010 Nov;78(6):372-81
pubmed: 20533385
Science. 2008 Mar 21;319(5870):1676-9
pubmed: 18323416
Acta Neuropathol. 2010 Oct;120(4):529-35
pubmed: 20544211
J Allergy Clin Immunol. 2014 Aug;134(2):276-84
pubmed: 25087226
Mol Cell Biol. 2013 Jan;33(2):429-43
pubmed: 23149938
Front Immunol. 2018 Dec 12;9:2944
pubmed: 30619304
J Clin Immunol. 2015 Jan;35(1):32-46
pubmed: 25352053
Immunity. 2014 May 15;40(5):692-705
pubmed: 24792914
J Exp Med. 2013 Oct 21;210(11):2273-88
pubmed: 24127483